FY27

Biocon Q1 FY27 Revenue Rises 10% to Rs 4,336 Crore as Biopharma Business Leads Growth

By BiotechReality Business Intelligence Desk
6 August 2026

Biocon Limited posted a 10% YoY rise in Q1 FY27 consolidated revenue to Rs 4,336 crore, powered by 17% biopharma growth, a 349% jump in net profit, and continued biosimilar launches across the US and Canada.

News Business Healthcare & Pharmaceuticals

Sun Pharma Q1FY27 Results: Sales Rise 10.1% to Rs1,518 Mn

By BiotechReality Business Intelligence Desk
3 August 2026

Sun Pharma’s Q1FY27 results show consolidated sales up 10.1% to Rs. 151,836 million, net profit at Rs. 28,948 million, and 16% growth in India Formulations, as the Organon acquisition clears a key shareholder milestone ahead of an early-2027 close.

Tag: FY27

Biocon Q1 FY27 Revenue Rises 10% to Rs 4,336 Crore as Biopharma Business Leads Growth

Sun Pharma Q1FY27 Results: Sales Rise 10.1% to Rs1,518 Mn

Areas Covered

Discover More

Novartis Cosentyx PMR Receives Positive CHMP Opinion for Polymyalgia Rheumatica in Europe

Novo Sogroya CHMP Opinion: EMA Recommends Once-Weekly Somapacitan for Idiopathic Short Stature

Novo: FREHEMGO Haemophilia A Prophylaxis Wins Positive CHMP Opinion for EU Approval

Clinical Trial Failures 2026: AstraZeneca, Novartis and Kyowa Kirin Report a Wave of Phase 2 and Phase 3 Setbacks

Charles River Laboratories Accelerates Drug Development with Charles River Rapid Cell Banking Platform

Gilead Accelerates Global Access Strategy for Gilead Once-Yearly Lenacapavir in HIV Prevention Push